Trandolaprilat Inhibitor

MBS5756529 is an inhibitor targeting Trandolaprilat. Trandolaprilat is an inhibitor of non-sulfhydryl angiotensin-converting enzyme.

Li X, Liu C, Wu M, Zhang H, Sun Y, Cheng L, Chen H, Liu C, Yang L, Zhang Q, Cao Y, Gu J, Ding Y. Pharmacokinetics, Pharmacodynamics, and Tolerability of Single and Multiple Doses of Trandolapril, an Effective Angiotensin-Converting Enzyme Inhibitor, in Healthy Chinese Subjects. Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):373-84. doi: 10.1007/s13318-015-0277-2. PubMed PMID: 25864194.
Nirogi RV, Kandikere VN, Shrivastava W, Mudigonda K. Quantification of trandolapril and its metabolite trandolaprilat in human plasma by liquid chromatography/tandem mass spectrometry using solid-phase extraction. Rapid Commun Mass Spectrom. 2006;20(24):3709-16. PubMed PMID: 17117442.
Vidal M, Joly G, Mombouli JV, Boulanger CM, Vanhoutte PM. The endothelium and vascular effects of the ACE inhibitor trandolaprilat. J Cardiovasc Pharmacol. 1994;23 Suppl 4:S1-5. PubMed PMID: 7527094.
Tanonaka K, Kamiyama T, Takezono A, Sakai K, Takeo S. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart. J Mol Cell Cardiol. 1996 Aug;28(8):1659-70. PubMed PMID: 8877776.

Small volumes of Trandolaprilat, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.